Analysts Set DocGo Inc. (NASDAQ:DCGO) Price Target at $3.21

Shares of DocGo Inc. (NASDAQ:DCGO) have earned a consensus rating of “Hold” from the seven ratings firms that are presently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and two have issued a buy rating on the company. The average 12-month price objective among analysts that have covered the stock in the last year is $3.2125.

A number of analysts have recently weighed in on the stock. Zacks Research raised shares of DocGo from a “strong sell” rating to a “hold” rating in a report on Thursday, November 6th. Weiss Ratings reiterated a “sell (d)” rating on shares of DocGo in a research note on Monday, December 15th. Finally, Canaccord Genuity Group lowered their price target on DocGo from $1.60 to $1.50 and set a “buy” rating for the company in a report on Wednesday, November 12th.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the company. Nuveen LLC bought a new stake in DocGo in the first quarter valued at $649,000. Russell Investments Group Ltd. grew its stake in shares of DocGo by 59.0% in the 1st quarter. Russell Investments Group Ltd. now owns 229,213 shares of the company’s stock valued at $605,000 after buying an additional 85,097 shares during the period. American Century Companies Inc. grew its stake in shares of DocGo by 175.5% in the 1st quarter. American Century Companies Inc. now owns 1,245,894 shares of the company’s stock valued at $3,289,000 after buying an additional 793,640 shares during the period. Birchview Capital LP increased its position in DocGo by 13.1% in the 1st quarter. Birchview Capital LP now owns 864,062 shares of the company’s stock valued at $2,281,000 after buying an additional 100,000 shares in the last quarter. Finally, AQR Capital Management LLC raised its stake in DocGo by 219.1% during the 1st quarter. AQR Capital Management LLC now owns 476,645 shares of the company’s stock worth $1,258,000 after buying an additional 327,269 shares during the period. Institutional investors own 56.44% of the company’s stock.

DocGo Stock Up 1.2%

NASDAQ:DCGO opened at $0.93 on Thursday. The company has a market cap of $90.64 million, a P/E ratio of -1.78 and a beta of 0.93. DocGo has a twelve month low of $0.86 and a twelve month high of $5.68. The business has a 50 day moving average price of $1.03 and a two-hundred day moving average price of $1.33.

DocGo (NASDAQ:DCGO) last released its earnings results on Monday, November 10th. The company reported ($0.11) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.09) by ($0.02). DocGo had a negative net margin of 14.02% and a negative return on equity of 9.11%. The company had revenue of $70.81 million during the quarter, compared to analyst estimates of $69.96 million. As a group, analysts anticipate that DocGo will post 0.25 earnings per share for the current fiscal year.

DocGo Company Profile

DocGo, Inc is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.

In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging.